Cognition Therapeutics, Inc., (the Company or Cognition) (NASDAQ: CGTX), a clinical-stage company developing drugs that treat neurodegenerative disorders, announced plans to advance development of ...
A new study shows how dysfunctional packaging of the neurotransmitter dopamine triggers toxic processes in neurons—and how ...
Cognition Therapeutics, Inc., (the Company or Cognition) (NASDAQ: CGTX), a clinical-stage company developing drugs that treat neurodegenerative disorders ...
Irish Mirror on MSN
Scientists pinpoint brain's 'early warning sign' which may signal Parkinson's or dementia
A new study has found that depression can be an early warning sign of Parkinson's disease and Lewy body dementia, appearing up to eight years before diagnosis ...
Depression could be an early warning sign that may appear up to eight years before a diagnosis of Parkinson's disease or Lewy ...
Late-onset depression may be an early sign of Parkinson’s disease (PD) or Lewy Body dementia (LBD), according to a December study published in General Psychiatry.
A children’s book written in the shadow of a life-changing diagnosis is now being used to support dementia awareness.
Phantasm' star Reggie Bannister needs financial help as he battles Lewy Body Dementia and Parkinson's disease ... because he has to move to a full-time care facility, and it's expensive.
News-Medical.Net on MSN
ATP delivery fixes dysfunctional dopamine packaging in Parkinson's neurons
A new study shows how dysfunctional packaging of the neurotransmitter dopamine triggers toxic processes in neurons - and how ...
Acadia Pharmaceuticals' two approved drugs, NUPLAZID and DAYBUE are guided to continue their strong growth trajectories. Read ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results